Immunobiology and clinical importance of the complement system of man.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Advances in Pediatrics

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/s0065-3101(22)00733-2PMID 341668
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum complement-like opsonic activities in human, animal, vegetable, and proprietary milks.

  1977cited by this paper
• The complement abnormalities of lipodystrophy.

  1976cited by this paper
• Intraarticular activation of the complement system in patients with juvenile rheumatoid arthritis.

  1976cited by this paper
• Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.

  1976cited by this paper
• Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.

  1976cited by this paper
• Interaction of properdin convertase and properdin in the alternative pathway of complement activation.

  1976cited by this paper
• Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis.

  1976cited by this paper
• Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis.

  1976cited by this paper
• Evidence that C1s participates in the alternative complement pathway.

  1976cited by this paper
• 46,XY/46,XY,21q- mosaicism in an infant with neutropenia and properdin deficiency.

  1976cited by this paper
• Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

  1976cited by this paper
• Serum and Blister Fluid Anticomplementary Activity in Pemphigus and Bullous Pemphigoid. Sucrose Density Gradient Studies 1

  1976cited by this paper
• Circulating immune complexes and complement sequence activation in infectious mononucleosis.

  1976cited by this paper
• Classical complement pathway activation in membranoproliferative glomerulonephritis.

  1976cited by this paper
• The glomerular complement receptor in immunologically mediated renal glomerular injury.

  1976cited by this paper
• Interaction of soluble C3 fragments with guinea pig lymphocytes. Comparison of effects of C3a, C3b, C3c, and C3d on lymphokine production and lymphocyte proliferation.

  1976cited by this paper
• Activation of the complement sequence by extracts of bacteria and fungi associated with hypersensitivity pneumonitis.

  1976cited by this paper
• Alternative complement pathway activity in sera from patients with sickle cell disease.

  1976cited by this paper
• A family with partial and total deficiency of complement C3.

  1976cited by this paper
• Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

  1976cited by this paper
• Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.

  1976cited by this paper
• Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway

  1976cited by this paper
• Complement : mechanisms and functions

  1976cited by this paper
• Shunt nephritis: the nature of the serum cryoglobulins and their relation to the complement profile.

  1976cited by this paper
• C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

  1976cited by this paper
• Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.

  1976cited by this paper
• Evidence That Cobra Venom Factor (CoF) Is Cobra C3

  1976cited by this paper
• Complement-mediated bactericidal system: evidence for a new pathway of complement action

  1975cited by this paper
• C4 LEVELS AND CLASSIFICATION OF BRONCHIAL ASTHMA

  1975cited by this paper
• Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.

  1975cited by this paper
• Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.

  1975cited by this paper
• HEPATITIS-B ANTIGENÆMIA ASSOCIATED WITH ACTIVE CHRONIC HEPATITIS AND MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS

  1975cited by this paper
• Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

  1975cited by this paper
• C1-BYPASS COMPLEMENT-ACTIVATION PATHWAY IN PATIENTS WITH CHRONIC URTICARIA AND ANGIO-ŒDEMA

  1975cited by this paper
• Complete absence of the third component of complement in man.

  1975cited by this paper
• Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

  1975cited by this paper
• Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions

  1975cited by this paper
• Genetic linkage between the HL-A system and a deficit of the second component (C2) of complement.

  1975cited by this paper
• Pathology of chemotaxis and random mobility.

  1975cited by this paper
• Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

  1975cited by this paper
• A receptor for the third component of complement in the human renal glomerulus

  1975cited by this paper
• The identification of a previously unrecognized subcomponent of the first component of complement.

  1975cited by this paper
• Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor

  1975cited by this paper
• Serum complement and immunoconglutinin in malnutrition.

  1975cited by this paper
• Interactions of C-reactive protein with the complement system. II. C- reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations

  1975cited by this paper
• Carboxypeptidase B-like activity and C3 in cystic fibrosis.

  1975cited by this paper
• Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum

  1975cited by this paper
• Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques.

  1975cited by this paper
• The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation.

  1975cited by this paper
• Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.

  1975cited by this paper
• Stimulation of neutrophil oxidative metabolism by the alternate pathway of complement activation: a mechanism for the spontaneous NBT test.

  1975cited by this paper
• A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

  1975cited by this paper
• Hereditary deficiency of the seventh component of complement.

  1975cited by this paper
• Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

  1975cited by this paper
• C1 INACTIVATOR FROM CANCER CELLS

  1974cited by this paper
• COMPLEMENT-DEPENDENT B-CELL ACTIVATION BY COBRA VENOM FACTOR AND OTHER MITOGENS?

  1974cited by this paper
• New biological activity following intravascular activation of the complement cascade

  1974cited by this paper
• Synthesis and metabolism of complement proteins.

  1974cited by this paper
• THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION

  1974cited by this paper
• Abnormalities of the complement system in clinical transplantation situations.

  1974cited by this paper
• Immediate Complement Consumption in Human Renal Allografts

  1974cited by this paper
• Role of C3 in in vitro lymphocyte cooperation

  1974cited by this paper
• Evidence for in vivo Reaction of Antibody and Complement to Surface Antigens of Human Cancer Cells

  1974cited by this paper
• Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.

  1974cited by this paper
• Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology.

  1974cited by this paper
• Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex.

  1974cited by this paper
• Alterations of serum opsonins in patients with severe thermal injury.

  1974cited by this paper
• Evidence for the activation of complement via the alternate pathway in skin diseases. II. Dermatitis herpetiformis.

  1974cited by this paper
• Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.

  1974cited by this paper
• A major role of the fifth component of complement (C5) in the opsonization of yeast particles. Partial dichotomy of function and immunochemical measurement.

  1974cited by this paper
• Complement components and IgE in bronchial asthma.

  1974cited by this paper
• Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors

  1974cited by this paper
• Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.

  1974cited by this paper
• Complement and mesangiocapillary glomerulonephritis role of complement deficiency in the pathogenesis of nephritis.

  1974cited by this paper
• Influence of the Alternate Complement Pathway on Opsonization of Several Bacterial Species

  1974cited by this paper
• Complement and the immunohistology of renal disease.

  1974cited by this paper
• The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.

  1973cited by this paper
• Opsonic activity in the newborn: role of properdin.

  1973cited by this paper
• Chemotactic factor inactivator in normal human serum.

  1973cited by this paper
• A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.

  1973cited by this paper
• The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.

  1973cited by this paper
• Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.

  1973cited by this paper
• SERUM-MEDIATED LEUKEMIA CELL DESTRUCTION IN AKR MICE

  1973cited by this paper
• FORMATION OF A HEMOLYTICALLY ACTIVE CELLULAR INTERMEDIATE BY THE INTERACTION BETWEEN PROPERDIN FACTORS B AND D AND THE ACTIVATED THIRD COMPONENT OF COMPLEMENT

  1973cited by this paper
• C2 deficiency. Development of lupus erythematosus.

  1973cited by this paper
• Depletion of complement during graft-versus-host reaction in a severe combined immunodeficiency patient after receiving a mismatched marrow transplant.

  1973cited by this paper
• Alternate complement pathway: elevation of cobra venom-induced hemolytic activity in sera of tumor-bearing mice.

  1973cited by this paper
• Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.

  1973cited by this paper
• Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis.

  1973cited by this paper
• The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.

  1973cited by this paper
• Glomerular Deposition of Properdin in Henoch-Schönlein Syndrome and Idiopathic Focal Nephritis

  1973cited by this paper
• Complement Inhibition After Canine and Human Renal Allotransplantation

  1973cited by this paper
• Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

  1973cited by this paper
• The role of complement in human immediate hypersensitivity: evidence against involvement of the alternate pathway of complement activation.

  1973cited by this paper
• Plasma C3 and C4 Concentrations in Management of Glomerulonephritis

  1973cited by this paper
• Anticomplementary sera in cutaneous vasculitis

  1973cited by this paper
• Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.

  1973cited by this paper
• The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus.

  1973cited by this paper
• Biologic role of rheumatoid factor? Relationship between antiglobulin consumption and complement system activation during bacteremia in man.

  1973cited by this paper
• Changes in arteriovenous complement activity induced by inhalation challenge.

  1973cited by this paper

• Bactericidal activity of middle ear effusion on a single isolate of non-typable Haemophilus influenzae.

  1988cites this paper
• In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.

  1986cites this paper
• Components of the Alternative Pathway of Complement in Otitis Media with Effusion

  1985cites this paper
• Abnormalities in the alternative pathway of complement in psoriasis

  1982cites this paper
• Characterization of a C3/C3b regulatory protein in normal human serum.

  1980cites this paper
• Alteration of the complement system in children with acquired thyroid disease.

  1980cites this paper
• Alteration of the complement system in children with Henoch Schönlein purpura.

  1978cites this paper